Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shalman DM"'
What Constitutes Quality of Life? Perspectives of Adolescents and Young Adults With Advanced Cancer.
Autor:
Hinkle J; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, California., Brock KE; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia., Casperson M; Divisions of Pediatric Oncology and Palliative Care, Cactus Cancer Society, Oakland, California., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, California., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena, California., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Dec; Vol. 21 (12), pp. 1243-1250.
Autor:
Mastropolo R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland., Brock KE; Department of Pediatric Oncology, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia., Casperson M; Divisions of Pediatric Oncology and Palliative Care, Cactus Cancer Society, Oakland, California., Chao CR; Department of Research and Evaluation (C.R.C.), Kaiser Permanente Southern California, Pasadena., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Greenzang KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wiener L; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Aug 01; Vol. 6 (8), pp. e2328153. Date of Electronic Publication: 2023 Aug 01.
Autor:
Mack JW; Division of Population Sciences (JWM, LF, AK), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S.; Department of Pediatric Oncology (JWM, AL, CBW), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S.. Electronic address: Jennifer_mack@dfci.harvard.edu., Fisher L; Division of Population Sciences (JWM, LF, AK), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S., Khalaj A; Division of Population Sciences (JWM, LF, AK), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S., Altschuler A; Department of Pediatric Oncology (JWM, AL, CBW), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S.; Division of Research (LHK, AA), Kaiser Permanente Northern California, Oakland, California, U.S., Chao CR; Department of Research and Evaluation (CRC), Kaiser Permanente Southern California, Pasadena, California, U.S., Kushi LH; Division of Research (LHK, AA), Kaiser Permanente Northern California, Oakland, California, U.S., Casperson M; Cactus Cancer Society (MC), Oakland, California, U.S., Lakin JR; Department of Psychosocial Oncology and Palliative Care (JRL), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S., Lefebvre A; Department of Pediatric Oncology (JWM, AL, CBW), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S., Schwartz CM; Medical Oncology (CMS), Kaiser Permanente Northern California, Oakland, California, U.S., Shalman DM; Palliative Care (DMS), Kaiser Permanente Southern California, Pasadena, California, U.S., Wall CB; Department of Pediatric Oncology (JWM, AL, CBW), Dana-Farber Cancer Institute, Boston, Massachusetts, U.S., Wiener L; Psychosocial Support and Research Program (LW), National Cancer Institute, Bethesda, Maryland, U.S.
Publikováno v:
Journal of pain and symptom management [J Pain Symptom Manage] 2023 Jul; Vol. 66 (1), pp. 54-61. Date of Electronic Publication: 2023 Mar 17.
Autor:
Umaretiya PJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Josephs I; Brown Medical School, Providence, Rhode Island, USA., Brock KE; Divisions of Pediatric Oncology and Palliative Care, Emory University, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Buchanan S; BeiGene, Cambridge, Massachusetts, USA., Casperson M; Cactus Cancer Society, Oakland, California, USA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, California, USA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, California, USA., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena, California, USA., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland, USA., Bona K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Jan; Vol. 70 (1), pp. e30035. Date of Electronic Publication: 2022 Oct 29.
Autor:
Odejide OO; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Josephs I; Brown Medical School, Providence, RI., Brock KE; Division of Pediatric Oncology, Emory University, Atlanta, GA.; Division of Palliative Care, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA., Buchanan S; Agios Pharmaceuticals, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Casperson M; Cactus Cancer Society, Oakland, CA., Cooper RM; Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, CA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA., Shalman DM; Palliative Care, Kaiser Permanente Southern California, Pasadena, CA., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, MD., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2022 Oct; Vol. 18 (10), pp. e1621-e1629. Date of Electronic Publication: 2022 Aug 18.
Autor:
Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Kushi L; Division of Research, Kaiser Permanente Northern California, Oakland., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Josephs I; Brown Medical School, Providence, Rhode Island., Brock KE; Divisions of Pediatric Oncology and Palliative Care, Emory University and Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia., Buchanan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Now with Agios Pharmaceuticals, Cambridge, Massachusetts., Casperson M; Lacuna Loft, Oakland, California., Cooper RM; Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2121888. Date of Electronic Publication: 2021 Aug 02.